Super-response to renal denervation in treatment-resistant essential hypertension

BMJ Case Rep. 2024 Aug 29;17(8):e260945. doi: 10.1136/bcr-2024-260945.

Abstract

Renal denervation may be indicated in patients with treatment-resistant essential hypertension to decrease sympathetic nervous activity and optimise blood pressure. We present the case of a woman in her 50s with long-standing essential hypertension, a previous transient ischaemic attack, obesity and a family history of cardiovascular disease, who presented with persistent 24-hour ambulatory hypertension despite ongoing lifestyle modifications and being on five antihypertensive agents with no evidence of an alternative primary aetiology. She had intermittent palpitations and blurring of vision alongside evidence of left ventricular hypertrophy on a CT scan. She underwent renal denervation, following which, not only was she able to cease all antihypertensive therapy but managed to maintain optimised blood pressure with subsequent reversal of left ventricular hypertrophy. Trials have demonstrated modest but inconsistent reductions in blood pressure whereas our case represents a 'super-response' likely due to a higher number of circumferential ablations in comparison to previous studies.

Keywords: Hypertension; Interventional cardiology; Renal intervention.

Publication types

  • Case Reports

MeSH terms

  • Antihypertensive Agents / therapeutic use
  • Blood Pressure / physiology
  • Essential Hypertension* / drug therapy
  • Essential Hypertension* / surgery
  • Female
  • Humans
  • Hypertrophy, Left Ventricular
  • Kidney* / innervation
  • Middle Aged
  • Sympathectomy* / methods
  • Treatment Outcome

Substances

  • Antihypertensive Agents